05-Oct-17 A Chinese University department head sees opportunity as Hong Kong braces for 30% of its population to be older than 65, saying it should seize opportunities to develop biomedical technology that could boost the economy and provide better healthcare. [image: South China Morning Post]

05-Oct-17 Chinese drug firm Fosun Pharma has acquired a 74% controlling interest of Hyderabad based Gland Pharma at a valuation of USD1.1 bn. The new owners intend to keep present management in charge of the day-to-day running of the company. [image: Gland Pharma Limited]

03-Oct-17 Beijing Hospital, one of China's leading public hospitals, is to implement OmniComm's phase I clinic trial automation solution, bringing the number of China clients for its TrialOne medical trial data management solution to seven. [image: OmniComm Systems Inc]

28-Sep-17 In Jun-17 Myanmar relaxed prohibitions on foreign trading, allowing 100% foreign-owned companies to sell certain hospital equipment. Myanmar needs to be less reliant on offshore manufacturing. With the increase in private medical insurance, opportunities abound for investors. [image: The Myanmar Times]

28-Sep-17 According to the Korean government's biotechnology development plan, the government will increase the number of new drug candidates by 100 to 185 in 2026 and help companies come up with at least five new blockbuster drugs. [image: Business Korea]